Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In an ovarian cancer case study, Dr. Feldman uses this instrumentation to modernize pathology.
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a colorectal case study, Dr. Galon uses this instrumentation to uncover more details about cancer and the immune system.
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a breast cancer case study, Dr. Rimm uses this instrumentation in her immune-oncology research.
Cancer researchers now can visualize more of a tumor than ever before using PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions. In a melanoma case study, Dr. Tumeh uses this instrumentation to develop biomarkers in his cancer immunology research.
PerkinElmer’s NexION 2000 Single Cell ICP-MS has the ability to detect metal in a single ovarian cancer cell, which will lead to new cancer strategies and therapies.
PerkinElmer's Phenoptics™ quantitative pathology research system helped researchers reveal a predictive biomarker for Merkel cell carcinoma.
In a medical first, UNC researchers engineer and record skin cells becoming cancer killers using PerkinElmer’s IVIS system.
Researchers at the University of Oklahoma have discovered potent polyphenols in brown seaweed that target and prevent the spread of pancreatic cancer cells. Their research is a potential blueprint for fighting the most lethal form of cancer, saving thousands of lives each year.
Groundbreaking research using PerkinElmer's Vectra multispectral imaging platform may lead to new immunotherapy treatments for cancer.
New multispectral cell imaging system aims to revolutionize tumor analysis